Standard Operating Procedure for Regulatory Intelligence Source Qualification and Review
| Department | Regulatory Affairs |
| SOP No. | RA/2026/636 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 09/04/2026 |
| Effective Date | 09/04/2026 |
| Review Date | 09/04/2028 |
Purpose
This Standard Operating Procedure (SOP) establishes a systematic approach for the qualification and review of regulatory intelligence sources utilized by the Regulatory Affairs department. The purpose is to ensure that all information used for regulatory decision-making, policy monitoring, and compliance activities is accurate, reliable, and current, thereby supporting the organization’s commitment to regulatory compliance and quality governance.
Scope
This SOP applies to all regulatory intelligence sources evaluated and used across the Regulatory Affairs function, including but not limited to government publications, regulatory agency websites, licensed databases, industry newsletters, and vendor-supplied information relevant to pharmaceuticals, medical devices, and healthcare products. It excludes internal data unrelated to regulatory compliance and any non-regulatory information sources.
Responsibilities
- Regulatory Intelligence Analysts: Execute source qualification, review information validity, and update source records.
- Regulatory Affairs Supervisors: Supervise the qualification process, review documentation, and ensure adherence to SOP.
- Quality Assurance (QA) Representatives: Verify compliance with regulatory standards and approve final qualification records.
- Document Control Personnel: Maintain SOP versions and archival records of source qualification documentation.
Accountability
The Regulatory Affairs Manager is accountable for the overall implementation, compliance monitoring, periodic review, escalation of issues, and ensuring the effectiveness of this SOP dedicated to regulatory intelligence source qualification and review.
Procedure
The following procedure outlines the comprehensive steps for qualifying and reviewing regulatory intelligence sources:
1. Identification of Sources: Regulatory Intelligence Analysts shall compile a list of potential intelligence sources relevant to the organization’s regulated products and markets. This includes governmental and international regulatory agencies, certified databases, and industry advisory bodies.
2. Prerequisite Checks: Analysts must verify that each source is accessible, regularly updated, and provides trustworthy and authoritative information. Any security or subscription requirements shall be documented.
3. Safety and Compliance Verification: Confirm that accessing and using the source complies with information security policies and contractual agreements. No unlawful or unlicensed use of proprietary data is permitted.
4. Qualification Assessment: Evaluate each source against predefined criteria including source credibility, frequency of updates, relevance to regulatory frameworks, and historical reliability. The analyst shall fill out a Source Qualification Form documenting the assessment details.
5. Review and Approval: Completed qualification forms shall be submitted to the Regulatory Affairs Supervisor for review. Any discrepancies or identified gaps in source reliability require re-assessment or alternate source search before approval.
6. In-process Controls: Regular monitoring of source accuracy and timeliness shall be conducted quarterly. Changes in source reliability or accessibility shall be reported and reassessed per this SOP.
7. Documentation and Record Retention: All qualification forms, review notes, and approval records shall be securely maintained as controlled documents in the regulatory documentation system. Records shall be retained for a minimum of five years or as per company policy and regulatory requirements.
8. Handling Deviations: Any deviations identified during source review (e.g., source no longer accessible or unreliable data) must be documented and managed through the established deviation reporting system, including corrective actions.
9. Training: Regulatory personnel involved in intelligence sourcing shall receive training on this SOP and related compliance requirements before being authorized to qualify and review sources.
10. Periodic Effectiveness Review: The Regulatory Affairs Manager will conduct bi-annual reviews of the source qualification program to ensure continued compliance, adequacy of sources, and alignment with regulatory changes.
This procedure ensures the organization utilizes high-quality, verified regulatory intelligence sources, supporting effective regulatory operations, audit readiness, and maintaining compliance integrity.
Abbreviations
- GMP – Good Manufacturing Practice
- QA – Quality Assurance
- SOP – Standard Operating Procedure
- RA – Regulatory Affairs
- API – Active Pharmaceutical Ingredient
Documents
Listed documents are essential for maintaining accurate records and ensuring compliance with regulatory intelligence source qualification requirements.
- Regulatory Intelligence Source Qualification Form (Annexure-1)
- Source Review Logbook (Annexure-2)
- Deviation Report Template for Source Issues (Annexure-3)
References
- ICH Q10 Pharmaceutical Quality System
- FDA Guidance on Regulatory Information Management
- EMA Policy on Use of External Regulatory Intelligence
- ISO 9001:2015 Quality Management Systems Requirements
- Company Quality Manual and Documentation Procedures
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Regulatory Intelligence Source Qualification Form
Purpose: To document the evaluation and qualification status of a regulatory intelligence source prior to its approved use within the organization.
| Source Name | International Regulatory Database |
| Type of Source | Online Database |
| Vendor/Provider | Global Regulatory Inc. |
| Access Method | Subscription-based Web Portal |
| Date of Qualification | 05/04/2026 |
| Reviewed By | Regulatory Intelligence Analyst |
| Criteria Evaluated | Credibility, Update Frequency, Relevance |
| Assessment Summary | Source provides up-to-date, validated regulatory updates from FDA, EMA, and WHO. Access secured via institutional subscription. |
| Qualification Status | Approved |
| Next Review Date | 05/07/2026 |
Signature: ________________________
Annexure-2: Source Review Logbook
Purpose: To record periodic reviews, monitoring activities, and any issues identified concerning approved regulatory intelligence sources.
| Date | Source Name | Reviewed By | Findings | Actions Taken |
|---|---|---|---|---|
| 01/07/2026 | International Regulatory Database | Regulatory Affairs Supervisor | Data updates confirmed timely; no discrepancies found. | Continued approval; next review scheduled for 01/10/2026. |
| 01/10/2026 | International Regulatory Database | Regulatory Intelligence Analyst | Subscription renewal pending; potential access interruption. | Escalated to management; alternate source search initiated. |
Annexure-3: Deviation Report Template for Source Issues
Purpose: To document and manage deviations related to the failure, inaccessibility, or reliability issues of qualified regulatory intelligence sources.
| Deviation No. | DR-RA-2026-001 |
| Date of Deviation | 10/10/2026 |
| Source Affected | International Regulatory Database |
| Description of Deviation | Subscription expired leading to loss of access during critical update period. |
| Immediate Action Taken | Temporary access granted via trial account; notified management. |
| Root Cause Analysis | Delayed renewal process and lack of automated alerts. |
| Corrective Action | Implement renewal alert system; assign responsible person. |
| Preventive Action | Annual audit of subscriptions and status tracking. |
| Reported By | Regulatory Intelligence Analyst |
| Reviewed By | QA Representative |
| Approved By | Regulatory Affairs Manager |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 09/04/2026 | 1.0 | Initial issue | New SOP creation |